Christopher Sim is a seasoned professional in the life sciences and consulting sectors, currently serving as Managing Director at Bull & Bear Life Sciences since June 2018, where expertise in analytical and commercial strategies is utilized to enhance client value. Concurrently, Christopher is involved in strategy and new product planning at Galapagos, guiding business development and pre-launch preparations. Previous roles include Engagement Manager at L.E.K. Consulting, Business Partner at AbbVie for the world's best-selling drug, Humira, and Strategic Planning Consultant at Allergan. Earlier experience at KPMG focused on transaction and restructuring advisory within healthcare and technology. Educational qualifications include a Master of Science in Molecular Medicine from Imperial College London, a Bachelor of Science in Biology from the University of Bristol, and an ACA from ICAEW.
This person is not in any teams
This person is not in any offices